Application of AS101 in Combination With Chemotherapy for Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS).
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2015
At a glance
- Drugs AS 101 (Primary) ; Antineoplastics
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes
- Focus Therapeutic Use
- Sponsors BioMAS
- 09 Feb 2015 Status changed from not yet recruiting to suspended as reported by ClinicalTrials.gov.
- 14 Aug 2013 Planned End Date changed from 1 Jan 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov.
- 14 Aug 2013 Planned initiation date changed from 1 Jan 2012 to 1 Jan 2014 as reported by ClinicalTrials.gov.